Health Technology Assessments

Health Technology Assessments (HTAs) are a comprehensive systematic review and critical analysis of available evidence for A SINGLE medical technology for which there are several published clinical trials and a substantial body of evidence. This report details an entire technology class for which there are one or more indications or patient populations in use.

Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.

Comparative Effectiveness of Endovenous Laser Therapy Versus Conventional Surgery for Symptomatic Varicose Veins: A Review of Reviews

Purpose of Technology: The goal of endovenous laser ablation (EVLA) is to use laser energy to seal off the damaged portions of varicose veins, prevent further varicose vein formation, eliminate associated discomfort, and improve cosmetic appearance. This therapy is intended primarily for the treatment of varicose veins that result from great saphenous vein (GSV), small sapheno…

Comparative Effectiveness Review of Robotically Assisted Hysterectomy

Purpose of Technology: Robotically assisted hysterectomy (RAH) is intended for the minimally invasive removal of the uterus as a treatment for various medical conditions, including benign conditions such as endometriosis, uterine fibroids, and uterine prolapse. It is also used to treat and stage malignant conditions such as cervical and endometrial cancers.

Rati…

Comparative Effectiveness Review of Cryoablation for Salvage Treatment of Recurrent Prostate Cancer Following Radiotherapy

Purpose of Technology: Cryoablation of the prostate gland provides a minimally invasive treatment option for the management of localized prostate cancer. The technique uses percutaneously inserted cryoprobes to freeze and thereby destroy cancerous prostate tissue.

Comparative Effectiveness Review of Cryoablation for Primary Treatment of Localized Prostate Cancer

The publication date for this report is June 8, 2017, with a corrigendum issued on July 27, 2017. See Publication History for details.

Purpose of Technology: Cryoablation of the prostate gland provides a minimally invasive treatment option for the management of localize…